Abstract
In 1981, we reported that one-year actuarial kidney graft survival was much better in recipients with no evidence of cytomegalovirus (CMV) infection than in recipients with primary CMV infection (1). At that time standard post-transplant therapy consisted of prednisone and azathioprine. Four-and-a-half-years ago azathioprine was replaced with cyclosporin. The present paper concerns graft survival in relation to CMV in these patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Spencer, E.S., Fjeldborg, O. and Andersen, H.K. Scand. J. Urol. Nephrol. Suppl. 64. 128–131, 1981.
Arnfred, J., Nielsen, C.M., Spencer, E.S. and Andersen, H.K., Scand. J. Infect. Dis. 19: 297–302, 1987.
Spencer, E.S., Fjeldborg, O. and Mordhorst, C-H. Dan. Med. Bull, (in press).
Jepsen, F.L. and Spencer, E.S. (in preparation)
Richardson, W.P., Colvin, R.B., Cheeseman, S.H. et al. N. Engl. J. Med. 305: 57–63, 1981.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Spencer, E.S., Fjeldborg, O., Andersen, H.K. (1989). The Influence of Cyclosporin on Cytomegalovirus-Related Kidney Graft Survival. In: Andreucci, V.E., Dal Canton, A. (eds) Current Therapy in Nephrology. Developments in Nephrology, vol 24. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0865-2_143
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0865-2_143
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8209-9
Online ISBN: 978-1-4613-0865-2
eBook Packages: Springer Book Archive